As a company listed on the Euronext Growth market in Paris, Europlasma undertakes to providing the financial community with regular, transparent and accessible information and in compliance with stock market regulations
Europlasma today announces its results for the six months ended June 30, 2017, which were subject to a limited review by Auditors and were approved by the Board of Directors on October 24, 2017.
